Feedback / Questions
LiProSal (lithium/proline/salicylate) - Alzamend Neuro
https://www.businesswire.com/news/home/20220505005399/en/Alzamend-Neuro-Announces-Initiation-of-Phase-IIA-Multiple-Ascending-Dose-Clinical-Trial-for-AL001-Treatment-of-Dementia-Related-to-Alzheimer%E2%80%99s
May 5, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next